These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial. Bago J, Halle ZB, Strinić D, Kućisec N, Jandrić D, Bevanda M, Tomić M, Bilić A. Wien Klin Wochenschr; 2002 Jun 28; 114(12):448-53. PubMed ID: 12422579 [Abstract] [Full Text] [Related]
16. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin]. Zala G, Schwery S, Giezendanner S, Flury R, Wüst J, Meyenberger C, Wirth HP. Schweiz Med Wochenschr; 1996 Feb 03; 126(5):153-8. PubMed ID: 8685685 [Abstract] [Full Text] [Related]
17. Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance. Hu Y, Zhu Y, Lu NH. Front Cell Infect Microbiol; 2017 Feb 03; 7():168. PubMed ID: 28529929 [Abstract] [Full Text] [Related]
18. Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders. Markham A, McTavish D. Drugs; 1996 Jan 03; 51(1):161-78. PubMed ID: 8741237 [Abstract] [Full Text] [Related]